EMA green lights Pfizer's COVID-19 pill

Health News
FILE PHOTO: Paxlovid, a Pfizer’s coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS

(Reuters) – The European Union’s drug regulator on Thursday conditionally approved the use of Pfizer Inc’s antiviral COVID-19 pill for treating adults at risk of severe illness, as the region scrambles to boost its arsenal to fight the highly infectious Omicron variant.

Source: Read Full Article

Related posts:
  1. Buddy Dessert, Apple and 13 Other Celebrity Kids Who Are Named After Food
  2. Online therapy, coaches help ease eating disorders
  3. Brain damage caused by long stays in space